Clinical Trials

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT06062602 2023-10-06

PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC

15 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT05992610 2023-08-15

iCHRTL

Phase NA Unknown

40 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

NCT05963334 2023-07-27

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Phase 1/2 Completed

49 enrolled

Classical hematology

Anemia, Neutropenia, Thrombocytopenia

NCT02855944 2023-06-09

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

349 enrolled 29 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT01367002 2023-05-17

Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer

61 enrolled 13 charts

Endometrial Neoplasms

NCT02659059 2023-04-05

CheckMate 568

324 enrolled 26 charts

Carcinoma, Non-Small-Cell Lung

NCT05371301 2022-05-12

Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer

Phase 3 Unknown

200 enrolled

Ovarian Neoplasms

NCT05294900 2022-03-25

NEOS

Phase 2 Unknown

79 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04982549 2021-08-06

A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC

Phase 2 Unknown

35 enrolled

Unresectable Stage III NSCLC

NCT04137653 2021-07-20

Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT

Phase 3 Recruiting

1,498 enrolled

Breast Neoplasms

NCT04337632 2021-04-08

Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer

Phase 3 Unknown

338 enrolled

Ovarian Neoplasms

NCT00576225 2020-10-19

CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL

Phase 3 Withdrawn

BreastGastrointestinalGynecologicHead & NeckThoracic

NSCLC

NCT02658214 2020-08-20

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Phase 1 Completed

32 enrolled

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT01314833 2020-05-19

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

1,570 enrolled

Primary Breast Cancer

NCT00226915 2020-02-17

Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma

637 enrolled

Phase EARLY_PHASE1 Unknown

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03940001 2019-09-09

A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer

20 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT00689156 2018-04-05

READ

2,015 enrolled

Breast Neoplasms

NCT02924909 2018-03-20

QUIMERA

Phase 2 Unknown

50 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT01160601 2017-04-19

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

86 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00584857 2017-01-27

A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer

30 enrolled 8 charts

Uterine Neoplasms

NCT00912444 2016-11-22

NATT

Phase 3 Terminated

102 enrolled

Breast Neoplasms

NCT02207361 2015-12-22

Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer

Phase 4 Unknown

120 enrolled

Breast Neoplasms

NCT00538603 2015-12-17

Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)

Phase NA Completed

8 enrolled

Carcinoma, Ovarian Epithelial

NCT00873119 2015-07-28

Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary